GlassScriptPhysician profile
Alexander B Gelfer
NPI 1689638462
$19,581.31
in general payments reported to CMS, 2019-2025
53 companies · $3,275 in 2025
The $3,275 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,889 · 2020: $1,575 · 2021: $3,006 · 2022: $3,202 · 2023: $2,785 · 2024: $2,850 · 2025: $3,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,778 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,778.26 |
| Education | $131.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,055.91 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $2,499.76 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,958.57 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $1,658.20 | 2019-2025 | Uptravi, Opsumit |
| Genzyme Corporation | $1,294.27 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $831.31 | 2020-2024 | Acthar |
| Insmed, INC. | $600.16 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $596.50 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $582.60 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $553.95 | 2019-2025 | Prolastin-C Liquid |
| Electromed, INC. | $552.14 | 2019-2025 | Smartvest |
| Pfizer INC. | $480.62 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $404.53 | 2019-2022 | |
| Inspire Medical Systems, INC. | $400.10 | 2024-2025 | Inspire |
| Amgen INC. | $387.28 | 2021-2025 | Tezspire, Repatha, Otezla |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $368.15 | 2019-2025 | Winrevair, Zerbaxa, Recarbrio |
| Bayer Healthcare Pharmaceuticals INC. | $367.26 | 2019-2023 | |
| United Therapeutics Corporation | $219.86 | 2020-2023 | Tyvaso |
| Teva Pharmaceuticals USA, INC. | $209.82 | 2019-2022 | |
| Genentech USA, INC. | $200.82 | 2019-2021 | |
| Lilly USA, LLC | $187.53 | 2022-2024 | Jardiance, Emgality, Zepbound |
| Inogen, INC. | $178.03 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Gilead Sciences, INC. | $163.11 | 2019-2021 | |
| Philips North America LLC | $148.24 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $136.20 | 2021-2025 | Glassia |
| Mallinckrodt Enterprises LLC | $133.39 | 2019 | |
| Biotronik INC. | $129.89 | 2023 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Biomonitor |
| Eisai INC. | $125.00 | 2019 | |
| Axsome Therapeutics, INC. | $99.78 | 2023-2024 | Sunosi |
| Viatris Specialty LLC | $78.36 | 2025 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.89 | 2022-2024 | Xifaxan |
| Portola Pharmaceuticals, LLC | $68.34 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $67.34 | 2019-2022 | |
| Pulmonx Corporation | $64.85 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Shire North American Group INC | $63.71 | 2019 | |
| Verona Pharma, INC. | $63.53 | 2025 | Ohtuvayre |
| Abbvie INC. | $59.61 | 2020-2023 | |
| Advanced Respiratory, INC | $57.74 | 2019-2021 | |
| Novo Nordisk INC | $51.92 | 2021-2023 | Wegovy |
| Exact Sciences Corporation | $51.41 | 2023-2025 | Cologuard Collection Kit |
| Vifor Pharma, INC. | $49.23 | 2025 | Zemaira, Veltassa |
| Circassia INC. | $44.77 | 2019 | |
| Alexion Pharmaceuticals, INC. | $44.59 | 2021-2022 | |
| 3b Medical, INC. | $40.03 | 2025 | Luna |
| Kowa Pharmaceuticals America, INC. | $35.66 | 2022 | |
| Vanda Pharmaceuticals INC. | $24.37 | 2021 | |
| Almatica Pharma LLC | $23.52 | 2022 | |
| Fisher & Paykel Healthcare INC | $21.69 | 2022 | |
| Kaleo, INC. | $17.04 | 2021 | |
| Ani Pharmaceuticals, INC. | $16.69 | 2023 | Purified Cortrophin Gel |
| Currax Pharmaceuticals LLC | $16.14 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.62 | 2019 | |
| Amarin Pharma, INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Gelfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.